Every material Form 8-K INTEST CORP has filed with the SEC since August 10, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
InTest reported third-quarter 2026 revenue of $35.1 million, up 34% from a year earlier but essentially flat sequentially, and net earnings of $1.9 million, or $0.15 per diluted share, versus a net loss a year earlier. Orders reached a record $49.4 million, lifting backlog to $59.7 million, and management guided fourth-quarter 2026 revenue to $34.0 million to $36.0 million.
Revenue of $35.1 million, up 33.7% year-over-year and down 0.7% from the second quarter of 2026
Net earnings of $1.9 million, or $0.15 per diluted share, versus a net loss of $0.9 million, or $(0.08), in the prior-year quarter
Orders of $49.4 million, up 31.3% year-over-year, led by Semi orders of $25.1 million; backlog of $59.7 million
Fourth-quarter 2026 outlook: revenue of $34.0 million to $36.0 million and gross margin of approximately 45%
InTest said preliminary third-quarter 2026 orders are expected at $48 million to $50 million, a record driven by back-end semiconductor orders, and revenue is expected at the high end of its $33 million to $35 million guidance range. Backlog at September 30, 2026 is expected at $58 million to $60 million. The figures are preliminary and subject to the completion of financial closing procedures, and the company plans to report full third-quarter results on November 6, 2026.
Q3 2026 orders expected at $48 million to $50 million, up 28% to 33% from Q3 2025, led by record back-end semiconductor orders
Q3 revenue expected at the high end of the $33 million to $35 million guidance range, growth of more than 30% from $26.2 million in Q3 2025
Backlog at September 30, 2026 expected at $58 million to $60 million, up roughly 28% to 32% from $45.4 million at June 30, 2026
Full third-quarter results to be reported on November 6, 2026; figures are preliminary and may vary materially
InTest Corporation and M&T Bank signed an Eighth Amendment to the company's credit agreement on August 14, 2026. The amendment extends the period during which InTest may request advances under its term loan facility until August 28, 2028. The filing does not disclose any change in loan amount, interest rate, or other economic terms.
Eighth Amendment to the Amended and Restated Loan and Security Agreement dated August 14, 2026
Term loan advance request period extended to August 28, 2028
Agreement is with M&T Bank and covers several InTest subsidiaries, including Ambrell Corporation and Temptronic Corporation
InTest reported second-quarter 2026 revenue of $35.3 million, up 25.5% from a year earlier, and net earnings of $0.5 million, or $0.04 per diluted share, compared with a net loss of $0.5 million a year earlier. The company reiterated its full-year 2026 revenue outlook of $135.0 million to $140.0 million, which matters to shareholders because revenue and profit both improved while guidance did not change.
Revenue of $35.3 million, up 25.5% year-over-year and 4.2% from the first quarter of 2026.
Net earnings of $0.5 million, or $0.04 per diluted share, versus a net loss of $0.5 million, or $(0.04) per share, in the second quarter of 2025.
Gross margin fell to 40.5% from 42.6% a year earlier, which the company attributed to a shift toward lower-margin Auto/EV revenue.
Backlog of $45.4 million at June 30, 2026, up 19.8% year-over-year but down 12.4% from March 31, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every INTEST CORP filing is on SEC EDGAR ↗. 8-K briefs of other companies →